Form 4: Pfizer Executive Christoffel Boshoff Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Executive Vice President Christoffel Boshoff reports acquisition and disposal of Pfizer shares related to performance share awards.
Summary
- Christoffel Boshoff, an Executive Vice President at Pfizer Inc., reported changes in beneficial ownership of Pfizer common stock on February 28, 2024.
- The transactions involved the acquisition of 11,510 shares due to the earn-out of performance share awards, and the disposal of 4,150 shares to satisfy tax obligations.
- Following these transactions, Boshoff directly owns 156,007 shares of Pfizer common stock and indirectly owns 624 shares through a Rule 16b-3 plan.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Positives
- The acquisition of shares through performance awards suggests the executive is meeting performance goals.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine compensation and tax-related activities of an executive.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of the reported transactions: acquisition of shares from performance share awards and disposal of shares for tax obligations. |
| 03/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.